Similar to our observation, the gain of the 12q amplicon was previously found in individual ASPS cases [28,29], and the putatively amplified oncogenes on chromosome 12q (e.g., CDK4 and MDM2) were frequently seen in patients with soft tissue and bone tumors [30,31]. Here, CDK4 is linked to bone neoplasm.